Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Clinico-Investigative Profile of Hereditary Spastic Paraplegia in Children
Mahesh Kamate1, Mayank Detroja2
1Division of Pediatric Neurology, Department of Pediatrics, KAHER University's J N Medical College, In-charge Child Development Centre, KLES Prabhakar Kore Hospital, Belgaum, Karnataka, India.
Insights
Hereditary spastic paraplegia (HSP) is likely underdiagnosed in Indian children, with the recessive form being more common. Early recognition and genetic testing are crucial for timely diagnosis and management of this neurogenetic disorder.
Area of Science:
- Neurogenetics
- Pediatric Neurology
Background:
- Hereditary spastic paraplegia (HSP) is a group of neurogenetic disorders primarily affecting adults.
- Genetic advancements have identified over 78 HSP types, with increasing pediatric cases.
- Limited literature exists on pediatric HSP in India.
Purpose of the Study:
- To investigate the prevalence and characteristics of pediatric Hereditary Spastic Paraplegia (HSP) in India.
- To highlight diagnostic challenges and patterns of HSP in Indian children.
Main Methods:
- Retrospective chart review of genetically confirmed HSP patients over six years.
- Analysis of clinical presentation, diagnostic delay, and MRI findings.
Main Results:
- Eleven pediatric HSP cases identified, presenting at a mean age of 21.7 months.
- Common symptoms included delayed walking, tip-toeing, and scissoring gait.
- Average diagnostic delay was 5.2 years; MRI revealed corpus callosum thinning and white-matter changes.
- Most cases were recessive HSP; one dominant case had a SPAST gene mutation.
Conclusions:
- Pediatric HSP may be more prevalent in India than previously thought.
- Recessive forms of HSP are more common in children.
- Lack of awareness contributes to significant diagnostic delays.
Introduction:
Hereditary spastic paraplegia (HSP) is a group of neurogenetic disorders seen mainly in adults. With the advancement in genetics, more than 78 types of HSP have been identified, with increasing identification of HSP in children. However, there is scant literature on this from India.
Materials And Methods:
Retrospective chart review of patients with HSP diagnosed in the last 6 years was done. The data were extracted and analyzed.
Results:
A total of 11 patients had a diagnosis of HSP (genetically confirmed), with mean age of presentation at 21.7 months. The main symptom at the time of presentation was delayed walking and/or abnormal gait in the form of tip-toeing and scissoring of limbs. The mean delay in diagnosis was 5.2 years after initial presentation. MRI of the presented children showed mainly thinning of corpus callosum and white-matter changes. All of them had gradual worsening spasticity, despite physiotherapy and drugs. Except one, all children had recessive form of spastic paraplegia. Child with autosomal dominant spastic paraplegia had heterozygous mutation in SPAST gene, which is known to present in the first 2 years of life.
Conclusions:
HSP is probably not uncommon. Recessive form of HSP is more frequently seen in children. Because of lack of awareness, there is delay in reaching the final diagnosis.
More Related Videos
07:32Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
Published on: February 9, 2020
09:05Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)
Published on: June 12, 2017
Related Concept Videos
Drug Dosing: Infants and Children
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Taping Over Different Ground Profiles
Profile Leveling and Cross Sections
Steps in Outbreak Investigation
Drug Dissolution: Requirements and Profile Comparison